Načítá se...

Pharmacodynamics, pharmacokinetics, and safety of ticagrelor in Chinese patients with stable coronary artery disease

AIM: The aim of the study was to assess ticagrelor's effects on inhibition of platelet aggregation (IPA), P2Y(12) reaction units (PRU, measure of platelet P2Y(12) receptor blockade), pharmacokinetic (PK) parameters and safety in Chinese patients with stable coronary artery disease (CAD). METHOD...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Clin Pharmacol
Hlavní autoři: Li, Haiyan, Guo, Jingchuan, Carlson, Glenn F., Teng, Renli
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4972151/
https://ncbi.nlm.nih.gov/pubmed/27038001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12950
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!